Clinical trials
Phase 3 Ocular Hypertension trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
158 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 3 |
| 2001 | 7 |
| 2002 | 1 |
| 2003 | 7 |
| 2004 | 3 |
| 2005 | 10 |
| 2006 | 7 |
| 2007 | 2 |
| 2008 | 7 |
| 2009 | 5 |
| 2010 | 11 |
| 2011 | 14 |
| 2012 | 2 |
| 2013 | 5 |
| 2014 | 9 |
| 2015 | 7 |
| 2016 | 6 |
| 2017 | 2 |
| 2018 | 9 |
| 2019 | 8 |
| 2020 | 4 |
| 2021 | 6 |
| 2022 | 5 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 4 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 131 |
| Recruiting | 8 |
| Withdrawn | 7 |
| Terminated | 6 |
| Unknown status | 4 |
| Not yet recruiting | 1 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alcon Research | 42 |
| Allergan | 18 |
| Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 10 |
| Santen Pharmaceutical Co., Ltd. | 10 |
| Aerie Pharmaceuticals | 8 |
| Santen Oy | 5 |
| AbbVie | 4 |
| Bausch & Lomb Incorporated | 4 |
| Glaukos Corporation | 4 |
| Merck Sharp & Dohme LLC | 4 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ocular Hypertension | 158 |
| Glaucoma, Open-Angle | 117 |
| Glaucoma | 65 |
| Hypertension | 9 |
| Cataract | 2 |
| Exfoliation Syndrome | 1 |
| Eye Diseases | 1 |
| Glaucoma, Angle-Closure | 1 |
Trials
Showing 76 to 100 of 158. Each trial links to its page on Pharma Observatory.
58 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.